Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
OnkoSight Advanced Bladder Cancer Panel BioReference Health United States | 1 | 39 |
|
OnkoSight Advanced Breast Cancer Panel BioReference Health United States | 1 | 50 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Myriad Genetics, Inc. United States | 32 | 46 |
|
Precise Tumor Molecular Profile Testing Myriad Genetics, Inc. United States | 14 | 6 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
EGFR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 118 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 115 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
Foundation Medicine, Inc. United States | 2 | 1 |
|
PathGroup United States | 73 | 505 |
|
Ambry Genetics United States | 79 | 80 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
Clinical Cancer Genomics Laboratory University of California, San Francisco United States | 2 | 2 |
|
GTC-Solid Tumor Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.